drugset / Trial / NCT01701739
A Pharmacokinetics Study of Aleglitazar in Combination With Digoxin in Healthy Volunteers
Non-randomizedSingle-groupOpen-label
Summary
This open-label, two-period, fixed-sequence study will investigate the pharmacokinetics and safety of multiple doses of aleglitazar on a single dose of digoxin in healthy volunteers. In period 1, volunteers will receive a single dose of digoxin, in period 2 volunteers will receive multiple doses of aleglitazar and a single dose of digoxin. The anticipated time on study treatment is one month.
Timeline
- Start
- 2012-10
- Primary completion
- 2013-01
- Completion
- 2013-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Digoxin | Other / unclassified | — | — |
| Subject | aleglitazar | Small molecule | — | — |
Indications
No indication recorded.